To assess whether KLK14 levels change during PCa progression, we analyzed KLK14 mRNA expression in advanced PCa using publicly available databases and KLK14 protein expression in PCa tissues obtained from untreated patients, from those responding to NHT and from patients with CRPC. This evidence concerns the gene KLK14 and posterior cortical atrophy.